James Lp
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
James Lp's research focuses on the development and validation of analytical techniques for identifying and quantifying substances in biological samples. His work includes the validation of "ToxBox Kits" designed to automate liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses, a method crucial for detecting emerging drug threats. Lp has also investigated the presence of specific synthetic cannabinoids, such as 5F-ADB, in impaired driving cases. His research extends to pharmacokinetic modeling, including an external evaluation of a model for meropenem in infants.
Lp has served as Principal Investigator on two NIH grants from the National Center for Advancing Translational Sciences, totaling over $8 million. These grants aim to expand translational science and research within Arkansas. His collaborations include work with researchers at the University of Arkansas for Medical Sciences, such as William E. Fantegrossi, Jeffery H. Moran, and Marina Avram, with whom he shares publications.
His scholarship metrics include an h-index of 1, with 4 total publications and 14 citations. Lp's recent activity is indicated by publications in 2026, suggesting ongoing engagement in research.
Metrics
- h-index: 1
- Publications: 3
- Citations: 14
Selected Publications
-
External Evaluation of a Plasma and Cerebrospinal Fluid Population Pharmacokinetics Model of Meropenem in Infants. (2026)
-
Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses (2026)
-
Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB (2018)
Federal Grants 2 $8,092,234 total
Collaboration Network
Top Collaborators
- Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB
- Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB
- Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB
- Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB
- Impaired Driving Associated with the Synthetic Cannabinoid 5F-ADB
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
- Outpacing Emerging Drug Threats: Validation of ToxBox Kits That Automate LC-MS/MS Analyses
Similar Researchers
Based on overlapping research topics